Abstract:Financing structure is an important and very complex issue in the financial theory and the rights and obligations of relevant stakeholders of enterprises are also concentrated in the financing structure. Therefore, the financing structure has a significant impact on the value of enterprises. A reasonable financing structure is conducive to standardizing the behavior of enterprises and improving the value of enterprises. The change of corporate financing structure is often used as a signal to external investors about the company's future income expectations, especially because the financing structure has a certain impact on the company's performance, which makes the problem of financing structure more valued by the theoretical and financial circles. For the empirical information about company financing, this paper explores the influencing elements of the company's running overall performance assisted with the aid of the blockchain, and the net of matters provides a chain model and constructs the operating performance indicators according to the comprehensive score. We select the commercial credit financing rate, short-term loan financing rate, long-term loan financing rate, debt financing rate, equity financing rate, and endogenous financing rate. The control variables are total capital, ownership concentration, and average age of the company. The conclusion is drawn by regression analysis. Commercial savings financing rate, fairness financing fee, and endogenous financing fee are positively correlated with the working performance; short-term loans and average age of the company are negatively correlated with the operating performance; and long-term loan financing rate, bond financing rate, and equity concentration are not significantly correlated with the operating performance.

The Nonlinear Effect of Financing Structure of Internet Listed Companies on Company Performance

Does the Development of the Internet Improve the Allocative Efficiency of Production Factors? Evidence from Surveys of Chinese Manufacturing Firms

Relations with non financial listed companies financing structure and corporate performance

The Impact of Different Financing Methods on Enterprise Performance: Evidence from Chinese High-tech Companies

Has Internet Finance Improved Social Financing Structure? ——Based on Model of Enterprise Financing Options

Relationship between Enterprise Financing Structure and Business Performance Assisted by Blockchain for Internet of Things Financing Mode

Initial Public Offering, Corporate Innovation and Total Factor Productivity: Evidence from China

The Nonlinear Effects of Digital Finance on Corporate ESG Performance: Evidence from China

The Effect of Ownership Structure on Leverage Decision: New Evidence from Chinese Listed Firms

FINANCING STRUCTURE AND INNOVATION---Evidence from A-share of Listing Corporation of Strategic Emerging Industries in China

Digital finance, corporate financialization and enterprise operating performance: an empirical research based on Chinese A-share non-financial enterprises

Financial Structure and Capital Allocation Efficiency: An Empirical Analysis of China from 2005–2018

Nonlinear Impact of the Digital Inclusive Finance on Enterprise Technological Innovation Based on the AK Model and PSTR Empirical Analysis

The Effect of Financing on Firm Innovation: Multiple Case Studies on Chinese Manufacturing Enterprises

The Regulation of the Financing of Stock Markets,and the Optimal Capital Structure of Companies

Impact of Financing Constraints on Firm Performance: Moderating Effect Based on Firm Size

The Impact of Capital Structure on the Performance of Chinese E-Commerce Industry Companies (2013–2019 Panel Data)

Nonlinear Impact of Corporate Financialization on Sustainable Development Ability: Evidence from Listed Companies in China

Internet finance and corporate investment: Evidence from China

The Effects of Financing Channels on Enterprise Innovation and Life Cycle in Chinese A-Share Listed Companies: An Empirical Analysis

Corporate financialization, financing constraints, and innovation efficiency—Empirical evidence based on listed Chinese pharmaceutical companies